Oral GLP-1 drugs are likely to expand the market massively The more disruptive development may actually be oral agents. Many patients are willing to take a pill but reluctant to self-inject indefinitely. Foundayo (orforglipron) – Lilly This is currently the most important oral competitor. Advantages: True oral GLP-1 No fasting requirement No water restrictions No injection training Lower manufacturing complexity than injectable peptides It received US approval for obesity in

Eli Lilly licensed global rights, excluding South Korea, to Hanmi Pharm's investigational long-acting GLP-2 analogue sonefpeglutide across multiple indications, under a deal potentially worth around $1.2 billion. The therapy, which is currently in Phase II development for the treatment of short bowel syndrome (SBS)-associated intestinal failure, employs Hanmi's LAPSCOVERY platform technology, enabling once-monthly subcutaneous administration. Hanmi will continue to conduct

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly PUBLISHED TUE, MAR 31 20267:39 AM EDTUPDATED TUE, MAR 31 20262:10 PM EDT Annika Kim Constantino @ANNIKAKIMC SHARE Share Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email KEY POINTS Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients pay low

https://mol.im/a/14668147

https://www.reuters.com/business/healthcare-pharmaceuticals/who-set-back-use-weight-loss-drugs-adults-globally-raises-cost-issue-2025-05-01/

Eli Lilly: A New Leader Is Coming Could the long-running obesity drugs leadership anchored by the Denmark-headquartered Novo Nordisk (...

we now have retatrutide available. 25 percent weight loss in 24 weeks. contact us www.weightloss.sc

1.6 million Brits set to get 'King Kong' of fat-busting jabs free.

Shares of Novo Nordisk NVO gained 4.2% on Sept. 11 after the company presented encouraging detailed efficacy data from the early-stage...

custom eating plan

https://youtu.be/nBI1WCmHRe4?si=OPOuI-Y3SffsIsEB a good documentary , worth watching👌

Booming demand for the latest generation of hormone-mimicking weight loss and diabetes drugs has elevated Novo Nordisk and its American...

Tirzepatide, the drug of choice for weight loss

Tirzapatide ( mounjaro) comes out on top

Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist approved for the treatment of type 2 diabetes in the USA, Europe, and the...

Beware of fake Ozempic and similar drugs.

Losing weight and simultaneously gaining control of your diabetes (type 2)

Obesity is a complex condition influenced by a variety of factors that affect all races. Key causes include: 1. Genetics: Genetic...